查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1790425

过敏和自体免疫疾病诊断市场规模、份额和趋势分析报告：按产品/服务、测试类型、诊断类型、最终用途、地区和细分市场预测，2025 年至 2033 年

Allergy And Autoimmune Disease Diagnostics Market Size, Share & Trends Analysis Report By Product & Service (Allergy Diagnostics), By Test Type, By Diagnostics Type, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 136 Pages | 商品交期: 2-10个工作天内

价格

过敏和自体免疫疾病诊断市场摘要

2024 年全球过敏和自体免疫疾病诊断市场价值估计为 113.8 亿美元，预计到 2033 年将达到 250.2 亿美元，2025 年至 2033 年的复合年增长率为 5.41%。该市场适用于检测和监测各种免疫相关疾病，包括过敏反应和自体免疫疾病。

慢性免疫疾病盛行率的上升、公众和临床医生意识的提升，以及免疫测量和分子平台等诊断方法的技术进步，推动了免疫诊断的成长。持续改善诊断的准确性、速度和可及性，尤其是照护现场和多重检测，正在显着改变这一格局。实验室基础设施的扩展、数位化工具的整合以及对个人化免疫诊断的兴趣，正在促进疾病的早期发现和长期管理策略的发展。生物标记研究和人工智慧主导的分析技术的创新有望进一步提高复杂自体自体免疫疾病诊断的准确性。

根据美国疾病管制与预防中心 (CDC) 于 2023 年 1 月发布的 2021 年全国健康访问调查 (NHIS) 报告，美国近三分之一的成年人和超过四分之一的儿童报告患有季节性过敏、湿疹或食物过敏。约 6% 的成年人和儿童患有食物过敏，非西班牙裔黑人的盛行率显着高于其他种族和族裔群体。这些数据反映了不同人群对诊断过敏相关疾病的需求日益增长，并凸显了过敏和自体免疫疾病诊断行业对更准确、更全面的检测方法的需求。

此外，市场正在见证家用检测和分散式检查解决方案日益融合，使得诊断服务能够更广泛地涵盖传统临床环境之外。诊断开发商、公共卫生机构和私人医疗机构之间的合作，正在提升地方卫生中心和药房的检测覆盖率。这些发展，加上免疫学研究投入的增加以及国家医疗保健计划扩大诊断覆盖范围，预计将在未来几年增强过敏和自体免疫疾病诊断市场。

目录

第 1 章过敏和自体免疫疾病诊断市场：调查方法和范围

第二章：过敏与自体免疫疾病诊断市场：执行摘要

  • 市场概述
  • 按产品/服务和测试类型分類的简介
  • 按诊断类型分類的简介
  • 按最终用途分類的简介
  • 竞争格局简介

3. 过敏和自体免疫疾病诊断市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
  • 市场驱动因素分析
    • 免疫相关疾病的盛行率不断上升
    • 迈向更早、更个人化的诊断
    • 扩大分散式和居家式检测
  • 市场限制因素分析
    • 先进诊断技术高成本
    • 新兴市场的诊断不足和认知度较低：
    • 监管和报销障碍
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第四章过敏和自体免疫疾病诊断市场：按产品和服务的估计和趋势分析

  • 过敏和自体免疫疾病诊断市场：按产品/服务进行的波动分析
  • 过敏诊断
    • 装置
    • 耗材
    • 服务
  • 自体免疫疾病的诊断
    • 装置
    • 耗材
    • 服务

第五章过敏和自体免疫疾病诊断市场：按测试类型估计和趋势分析

  • 过敏和自体免疫疾病诊断市场：按测试类型进行的波动分析
  • 过敏诊断
    • 体内测试
    • 试管内测试
    • 自体免疫疾病的诊断

第六章过敏和自体免疫疾病诊断市场：按诊断类型估计和趋势分析

  • 过敏和自体免疫疾病诊断剂市场：按诊断类型波动分析
  • 过敏诊断
    • 食物
    • 吸入
    • 药品
    • 其他过敏原
  • 自体免疫疾病的诊断
    • 系统性自体免疫疾病的诊断
    • 局部自体免疫疾病的诊断

第七章过敏和自体免疫疾病诊断市场：按最终用途的估计和趋势分析

  • 过敏和自体免疫疾病诊断市场：按最终用途进行的变化分析
  • 过敏诊断
    • 医院和诊所
    • 诊断实验室
    • 研究机构
    • 其他的
  • 自体免疫诊断
    • 医院和诊所
    • 诊断实验室
    • 研究所
    • 其他的

第 8 章：过敏和自体免疫疾病诊断市场：按地区分類的业务分析

  • 区域市场概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第九章 竞争态势

  • 公司分类
  • 战略地图
    • 推出新产品和服务
    • 伙伴关係
    • 获得
    • 合作
    • 资金筹措
  • 主要企业市场占有率分析（2024年）
  • 公司热图分析
  • 公司简介
    • THERMO FISHER SCIENTIFIC, INC.
    • HYCOR BIOMEDICAL
    • EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG（PERKINELMER, INC.）
    • OMEGA DIAGNOSTICS GROUP PLC
    • LINCOLN DIAGNOSTICS, INC.
    • AESKU.GROUP GMBH
    • MINARIS MEDICAL AMERICA, INC.
    • HOB BIOTECH GROUP CORP., LTD.
    • DASIT GROUP SPA
    • R-BIOPHARM AG
    • BIOMERIEUX
    • SIEMENS HEALTHCARE GMBH
    • HOFFMANN-LA ROCHE LTD
    • ABBOTT
    • BECKMAN COULTER, INC.
    • DANAHER CORPORATION
    • QUEST DIAGNOSTICS
    • NOVA DIAGNOSTICS PTE LTD.
Product Code: GVR-4-68040-681-7

Allergy And Autoimmune Disease Diagnostics Market Summary

The global allergy and autoimmune disease diagnostics market size was estimated at USD 11.38 billion in 2024 and is projected to reach USD 25.02 billion by 2033, growing at a CAGR of 5.41% from 2025 to 2033. This market addresses the detection and monitoring of immune-related conditions, spanning a wide range of allergic reactions and autoimmune disorders.

Growth is being supported by the rising incidence of chronic immune conditions, greater public and clinical awareness, and technological improvements in diagnostic modalities such as immunoassays and molecular platforms. Ongoing efforts to improve diagnostic accuracy, speed, and accessibility, especially through point-of-care formats and multiplex testing, are reshaping the landscape. Expanding laboratory infrastructure, integration of digital tools, and interest in personalized immunodiagnostics are contributing to early disease detection and long-term management strategies. Innovations in biomarker research and AI-driven analysis are expected to further support diagnostic precision in complex autoimmune profiles.

According to the National Health Interview Survey (NHIS), 2021, published by the U.S. Centers for Disease Control and Prevention (CDC) in a press release dated January 2023, nearly 1 in 3 adults and more than 1 in 4 children in the U.S. reported having a seasonal allergy, eczema, or food allergy. Around 6% of both adults and children suffer from a food allergy, with the rate being notably higher among Black, non-Hispanic individuals compared to other racial and ethnic groups. These figures reflect the growing diagnostic demand for allergy-related conditions across diverse populations, emphasizing the need for more accurate and inclusive testing approaches in the allergy and autoimmune disease diagnostics industry.

In addition, the market is witnessing greater integration of home-based and decentralized testing solutions, enabling broader access to diagnostics beyond traditional clinical settings. Collaborations between diagnostic developers, public health agencies, and private providers are enhancing the availability of tests in community health centers and pharmacies. These developments, combined with rising investments in immunology research and the expansion of diagnostic coverage under national health programs, are expected to strengthen the position of the allergy and autoimmune disease diagnostics market over the coming years.

Global Allergy And Autoimmune Disease Diagnostics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global allergy and autoimmune disease diagnostics market report based on product and service, diagnostics type, test type, end use, and region:

  • Product and Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Allergy Diagnostics
    • Instruments
    • Consumables
    • Services
  • Autoimmune Disease Diagnostics
    • Instruments
    • Consumables
    • Services
  • Test Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Allergy Diagnostics
    • In vivo Test
    • Skin Prick Test
    • Intradermal Test
    • Patch Test
    • In vitro Test
    • Autoimmune Disease Diagnostics
    • Antinuclear Antibody Tests
    • Autoantibody Tests
    • C-reactive Protein (CRP)
    • Complete Blood Count (CBC)
    • Urinalysis
    • Others
  • Diagnostics Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Allergy Diagnostics
    • Food
    • Dairy Products
    • Poultry Products
    • Tree Nuts
    • Peanuts
    • Shellfish
    • Wheat
    • Soys
    • Other Food Allergens
    • Inhaled
    • Drug
    • Other Allergens
  • Autoimmune Disease Diagnostics
    • Systemic Autoimmune Disease Diagnostics
    • Rheumatoid Arthritis
    • Ankylosing Spondylitis
    • Systemic Lupus Erythematosus (SLE)
    • Others
    • Localized Autoimmune Disease Diagnostics
    • Multiple Sclerosis
    • Type 1 Diabetes
    • Hashimoto's Thyroiditis
    • Idiopathic Thrombocytopenic Purpura
    • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Allergy Diagnostics
    • Hospitals & Clinics
    • Diagnostics Laboratories
    • Research Institutions
    • Others
  • Autoimmune Diagnostics
    • Hospitals & Clinics
    • Diagnostics Laboratories
    • Research Institutions
    • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Allergy and Autoimmune Disease Diagnostics Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product and Service Segment
      • 1.1.1.2. Test Type Segment
      • 1.1.1.3. Diagnostics Type Segment
      • 1.1.1.4. End Use segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Allergy and Autoimmune Disease Diagnostics Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product and Service and Test type Snapshot
  • 2.3. Diagnostics Type Snapshot
  • 2.4. End Use Snapshot
  • 2.5. Competitive Landscape Snapshot

Chapter 3. Allergy and Autoimmune Disease Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising Prevalence of Immune-Related Disorders
    • 3.4.2. Shift Toward Early and Personalized Diagnosis
    • 3.4.3. Expansion of Decentralized and Home-Based Testing
  • 3.5. Market Restraint Analysis
    • 3.5.1. High Cost of Advanced Diagnostic Technologies
    • 3.5.2. Underdiagnosis and Limited Awareness in Emerging Markets:
    • 3.5.3. Regulatory and Reimbursement Barriers
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Allergy and Autoimmune Disease Diagnostics Market: Product and Service Estimates & Trend Analysis

  • 4.1. Allergy and Autoimmune Disease Diagnostics Market: Product and Service Movement Analysis
  • 4.2. Allergy Diagnostics
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.2. Instruments
      • 4.2.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.3. Consumables
      • 4.2.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.4. Services
      • 4.2.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Autoimmune Disease Diagnostics
    • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Instruments
      • 4.3.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Consumables
      • 4.3.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.4. Services
      • 4.3.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Allergy and Autoimmune Disease Diagnostics Market: Test Type Estimates & Trend Analysis

  • 5.1. Allergy and Autoimmune Disease Diagnostics Market: Test Type Movement Analysis
  • 5.2. Allergy Diagnostics
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.2. In vivo Test
      • 5.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.2.2.2. Skin Prick Test
        • 5.2.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.2.2.3. Intradermal Test
        • 5.2.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.2.2.4. Patch Test
        • 5.2.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.3. In vitro Test
      • 5.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.4. Autoimmune Disease Diagnostics
      • 5.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.2.4.2. 'Antinuclear Antibody Tests
        • 5.2.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.2.4.3. Autoantibody Tests
        • 5.2.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.2.4.4. C-reactive Protein (CRP)
        • 5.2.4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.2.4.5. Complete Blood Count (CBC)
        • 5.2.4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.2.4.6. Urinalysis
        • 5.2.4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.2.4.7. Others
        • 5.2.4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Allergy and Autoimmune Disease Diagnostics Market: Diagnostics Type Estimates & Trend Analysis

  • 6.1. Allergy and Autoimmune Disease Diagnostics Market: Technology Movement Analysis
  • 6.2. Allergy Diagnostics
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.2. Food
      • 6.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.2.2.2. Dairy Products
        • 6.2.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.2.2.3. Poultry Products
        • 6.2.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.2.2.4. Tree Nuts
        • 6.2.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.2.2.5. Peanuts
        • 6.2.2.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.2.2.6. Shellfish
        • 6.2.2.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.2.2.7. Wheat
        • 6.2.2.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.2.2.8. Soys
        • 6.2.2.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.2.2.9. Other Food Allergens
        • 6.2.2.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.3. Inhaled
      • 6.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.4. Drug
      • 6.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.5. Other Allergens
      • 6.2.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Autoimmune Disease Diagnostics
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. Systemic Autoimmune Disease Diagnostics
      • 6.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.2.2. Rheumatoid Arthritis
        • 6.3.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.2.3. Ankylosing Spondylitis
        • 6.3.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.2.4. Systemic Lupus Erythematosus (SLE)
        • 6.3.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.2.5. Others
        • 6.3.2.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Localized Autoimmune Disease Diagnostics
      • 6.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.3.2. Multiple Sclerosis
        • 6.3.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.3.3. Type 1 Diabetes
        • 6.3.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.3.4. Hashimoto's Thyroiditis
        • 6.3.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.3.5. Idiopathic Thrombocytopenic Purpura
        • 6.3.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.3.6. Others
        • 6.3.3.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Allergy and Autoimmune Disease Diagnostics Market: End Use Estimates & Trend Analysis

  • 7.1. Allergy and Autoimmune Disease Diagnostics Market: End Use Movement Analysis
  • 7.2. Allergy Diagnostics
    • 7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.2. Hospitals & Clinics
      • 7.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.3. Diagnostics Laboratories
      • 7.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.4. Research Institutions
      • 7.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.5. Others
      • 7.2.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3. Autoimmune Diagnostics
    • 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Hospitals & Clinics
      • 7.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Diagnostics Laboratories
      • 7.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Research Institutions
      • 7.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.5. Others
      • 7.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Allergy and Autoimmune Disease Diagnostics Market: Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America Allergy and Autoimmune Disease Diagnostics Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Reimbursement Scenario
      • 8.2.2.5. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Reimbursement Scenario
      • 8.2.3.5. Competitive Scenario
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.2.4.2. Key Country Dynamics
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Reimbursement Scenario
      • 8.2.4.5. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. Competitive Scenario
    • 8.3.3. Germany
      • 8.3.3.1. Germany Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Competitive Scenario
    • 8.3.4. Spain
      • 8.3.4.1. Spain Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Competitive Scenario
    • 8.3.5. France
      • 8.3.5.1. France Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Reimbursement Scenario
      • 8.3.5.5. Competitive Scenario
    • 8.3.6. Italy
      • 8.3.6.1. Italy Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Reimbursement Scenario
      • 8.3.6.5. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Reimbursement Scenario
      • 8.3.7.5. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Reimbursement Scenario
      • 8.3.8.5. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Reimbursement Scenario
      • 8.3.9.5. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Competitive Scenario
    • 8.4.6. Thailand
      • 8.4.6.1. Thailand Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Competitive Scenario
    • 8.4.7. Australia
      • 8.4.7.1. Australia Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Reimbursement Scenario
      • 8.4.7.5. Competitive Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.5.2.2. Key Country Dynamics
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Competitive Scenario
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.5.3.2. Key Country Dynamics
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. Competitive Scenario
  • 8.6. MEA
    • 8.6.1. MEA Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Scenario
      • 8.6.4.5. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Scenario
      • 8.6.5.5. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. New Product and Service Launch
    • 9.2.2. Partnerships
    • 9.2.3. Acquisition
    • 9.2.4. Collaboration
    • 9.2.5. Funding
  • 9.3. Key Company Market Share Analysis, 2024
  • 9.4. Company Heat Map Analysis
  • 9.5. Company Profiles
    • 9.5.1. THERMO FISHER SCIENTIFIC, INC.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product and Service Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. HYCOR BIOMEDICAL
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product and Service Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG (PERKINELMER, INC.)
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product and Service Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. OMEGA DIAGNOSTICS GROUP PLC
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product and Service Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. LINCOLN DIAGNOSTICS, INC.
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product and Service Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. AESKU.GROUP GMBH
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product and Service Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. MINARIS MEDICAL AMERICA, INC.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product and Service Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. HOB BIOTECH GROUP CORP., LTD.
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product and Service Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. DASIT GROUP SPA
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product and Service Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. R-BIOPHARM AG
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product and Service Benchmarking
      • 9.5.10.4. Strategic Initiatives
    • 9.5.11. BIOMERIEUX
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Financial Performance
      • 9.5.11.3. Product and Service Benchmarking
      • 9.5.11.4. Strategic Initiatives
    • 9.5.12. SIEMENS HEALTHCARE GMBH
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Financial Performance
      • 9.5.12.3. Product and Service Benchmarking
      • 9.5.12.4. Strategic Initiatives
    • 9.5.13. HOFFMANN-LA ROCHE LTD
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Financial Performance
      • 9.5.13.3. Product and Service Benchmarking
      • 9.5.13.4. Strategic Initiatives
    • 9.5.14. ABBOTT
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Financial Performance
      • 9.5.14.3. Product and Service Benchmarking
      • 9.5.14.4. Strategic Initiatives
    • 9.5.15. BECKMAN COULTER, INC.
      • 9.5.15.1. Company Overview
      • 9.5.15.2. Financial Performance
      • 9.5.15.3. Product and Service Benchmarking
      • 9.5.15.4. Strategic Initiatives
    • 9.5.16. DANAHER CORPORATION
      • 9.5.16.1. Company Overview
      • 9.5.16.2. Financial Performance
      • 9.5.16.3. Product and Service Benchmarking
      • 9.5.16.4. Strategic Initiatives
    • 9.5.17. QUEST DIAGNOSTICS
      • 9.5.17.1. Company Overview
      • 9.5.17.2. Financial Performance
      • 9.5.17.3. Product and Service Benchmarking
      • 9.5.17.4. Strategic Initiatives
    • 9.5.18. NOVA DIAGNOSTICS PTE LTD.
      • 9.5.18.1. Company Overview
      • 9.5.18.2. Financial Performance
      • 9.5.18.3. Product and Service Benchmarking
      • 9.5.18.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Allergy and Autoimmune Disease Diagnostics Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Allergy and Autoimmune Disease Diagnostics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 5 Global Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 6 Global Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 7 Global Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 8 North America Allergy and Autoimmune Disease Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America Allergy and Autoimmune Disease Diagnostics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 10 North America Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 11 North America Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 12 North America Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 14 U.S. Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 15 U.S. Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 16 U.S. Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada Allergy and Autoimmune Disease Diagnostics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 18 Canada Allergy and Autoimmune Disease Diagnostics Market, by Product and Service, 2021 - 2033 (USD Million)
  • Table 19 Canada Allergy and Autoimmune Disease Diagnostics Market, by Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 20 Canada Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 22 Mexico Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 23 Mexico Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 24 Mexico Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe Allergy and Autoimmune Disease Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 26 Europe Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 27 Europe Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 28 Europe Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 29 Europe Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 UK Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 31 UK Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 32 UK Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 33 UK Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Germany Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 35 Germany Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 36 Germany Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 37 Germany Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 France Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 39 France Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 40 France Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 41 France Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 43 Italy Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 44 Italy Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 45 Italy Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 47 Spain Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 48 Spain Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 49 Spain Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 50 Sweden Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 51 Sweden Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 52 Sweden Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 53 Sweden Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Norway Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 55 Norway Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 56 Norway Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 57 Norway Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 Denmark Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 59 Denmark Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 60 Denmark Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 61 Denmark Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Allergy and Autoimmune Disease Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Japan Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 68 Japan Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 69 Japan Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 70 Japan Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71 China Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 72 China Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 73 China Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 74 China Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75 India Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 76 India Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 77 India Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 78 India Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 Australia Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 80 Australia Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 81 Australia Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 82 Australia Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 Thailand Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 84 Thailand Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 85 Thailand Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 86 Thailand Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 South Korea Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 88 South Korea Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 89 South Korea Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 90 South Korea Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America Allergy and Autoimmune Disease Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 92 Latin America Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 93 Latin America Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 94 Latin America Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 95 Latin America Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 97 Brazil Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 98 Brazil Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 99 Brazil Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 101 Argentina Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 102 Argentina Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 103 Argentina Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 104 MEA Allergy and Autoimmune Disease Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 105 MEA Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 106 MEA Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 107 MEA Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 108 MEA Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 110 South Africa Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 111 South Africa Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 112 South Africa Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 117 UAE Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 118 UAE Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 119 UAE Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 120 UAE Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2021 - 2033 (USD)
  • Table 122 Kuwait Allergy and Autoimmune Disease Diagnostics Market, By Product and Service, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Allergy and Autoimmune Disease Diagnostics Market, By Diagnostics Type, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Allergy and Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global Allergy and Autoimmune Disease Diagnostics Market- Key market driver analysis
  • Fig. 7 Global Allergy and Autoimmune Disease Diagnostics Market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global Allergy and Autoimmune Disease Diagnostics Market - Porter's analysis
  • Fig. 10 Global Allergy and Autoimmune Disease Diagnostics Market - PESTEL analysis
  • Fig. 11 Global Allergy and Autoimmune Disease Diagnostics Market Product and Service outlook key takeaways
  • Fig. 12 Global Allergy and Autoimmune Disease Diagnostics Market: Product and Service movement analysis
  • Fig. 13 Allergy Diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 14 Instruments market estimates, 2021 - 2033 (USD Million)
  • Fig. 15 Consumables market estimates, 2021 - 2033 (USD Million)
  • Fig. 16 Services market estimates, 2021 - 2033 (USD Million)
  • Fig. 17 Autoimmune Disease Diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 18 Instruments market estimates, 2021 - 2033 (USD Million)
  • Fig. 19 Consumables market estimates, 2021 - 2033 (USD Million)
  • Fig. 20 Services market estimates, 2021 - 2033 (USD Million)
  • Fig. 21 Global Allergy and Autoimmune Disease Diagnostics Market Test Type outlook key takeaways
  • Fig. 22 Global Allergy and Autoimmune Disease Diagnostics Market: Test Type movement analysis
  • Fig. 23 Allergy Diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 24 In vivo Test market estimates, 2021 - 2033 (USD Million)
  • Fig. 25 Skin Prick Test market estimates, 2021 - 2033 (USD Million)
  • Fig. 26 Intradermal Test market estimates, 2021 - 2033 (USD Million)
  • Fig. 27 Patch Test market estimates, 2021 - 2033 (USD Million)
  • Fig. 28 In vitro Test market estimates, 2021 - 2033 (USD Million)
  • Fig. 29 Autoimmune Disease Diagnostics Test market estimates, 2021 - 2033 (USD Million)
  • Fig. 30 Antinuclear Antibody Tests market estimates, 2021 - 2033 (USD Million)
  • Fig. 31 Autoantibody Tests estimates, 2021 - 2033 (USD Million)
  • Fig. 32 C-reactive Protein (CRP) market estimates, 2021 - 2033 (USD Million)
  • Fig. 33 Complete Blood Count (CBC) market estimates, 2021 - 2033 (USD Million)
  • Fig. 34 Urinalysis market estimates, 2021 - 2033 (USD Million)
  • Fig. 35 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 36 Global Allergy and Autoimmune Disease Diagnostics Market Diagnostics Type outlook key takeaways
  • Fig. 37 Global Allergy and Autoimmune Disease Diagnostics Market: Diagnostics Type movement analysis
  • Fig. 38 Allergy diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 39 Food market estimates, 2021 - 2033 (USD Million)
  • Fig. 40 Dairy products market estimates, 2021 - 2033 (USD Million)
  • Fig. 41 Poultry Products market estimates, 2021 - 2033 (USD Million)
  • Fig. 42 Tree nuts market estimates, 2021 - 2033 (USD Million)
  • Fig. 43 Peanuts market estimates, 2021 - 2033 (USD Million)
  • Fig. 44 Shellfish market estimates, 2021 - 2033 (USD Million)
  • Fig. 45 Wheat market estimates, 2021 - 2033 (USD Million)
  • Fig. 46 Soys market estimates, 2021 - 2033 (USD Million)
  • Fig. 47 Other food allergens market estimates, 2021 - 2033 (USD Million)
  • Fig. 48 Inhaled market estimates, 2021 - 2033 (USD Million)
  • Fig. 49 Drug market estimates, 2021 - 2033 (USD Million)
  • Fig. 50 Other allergens market estimates, 2021 - 2033 (USD Million)
  • Fig. 51 Autoimmune disease diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 52 Systemic autoimmune disease diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 53 Rheumatoid Arthritis market estimates, 2021 - 2033 (USD Million)
  • Fig. 54 Ankylosing Spondylitis market estimates, 2021 - 2033 (USD Million)
  • Fig. 55 Systemic Lupus Erythematosus (SLE) market estimates, 2021 - 2033 (USD Million)
  • Fig. 56 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 57 Localized Autoimmune Disease Diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 58 Multiple Sclerosis market estimates, 2021 - 2033 (USD Million)
  • Fig. 59 Type 1 Diabetes market estimates, 2021 - 2033 (USD Million)
  • Fig. 60 Hashimoto's Thyroiditis market estimates, 2021 - 2033 (USD Million)
  • Fig. 61 Idiopathic Thrombocytopenic Purpura market estimates, 2021 - 2033 (USD Million)
  • Fig. 62 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 63 Global Allergy and Autoimmune Disease Diagnostics Market end use outlook key takeaways
  • Fig. 64 Global Allergy and Autoimmune Disease Diagnostics Market: end use movement analysis
  • Fig. 65 Allergy Diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 66 Hospitals & Clinics market estimates, 2021 - 2033 (USD Million)
  • Fig. 67 Diagnostics Laboratories market estimates, 2021 - 2033 (USD Million)
  • Fig. 68 Research Institutions market estimates, 2021 - 2033 (USD Million)
  • Fig. 69 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 70 Autoimmune Diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 71 Hospitals & Clinics market estimates, 2021 - 2033 (USD Million)
  • Fig. 72 Diagnostics Laboratories market estimates, 2021 - 2033 (USD Million)
  • Fig. 73 Research Institutions market estimates, 2021 - 2033 (USD Million)
  • Fig. 74 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 75 Regional marketplace: Key takeaways
  • Fig. 76 Global Allergy and Autoimmune Disease Diagnostics Market: Regional movement analysis
  • Fig. 77 North America Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 78 U.S. Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 79 Canada Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 80 Mexico Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 81 Europe Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 82 UK Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 83 Germany Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 84 France Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 85 Spain Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 86 Italy Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 87 Denmark Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 88 Sweden Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 89 Norway Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 90 Asia Pacific Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 91 Japan Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 92 China Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 93 India Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 94 South Korea Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 95 Australia Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 96 Thailand Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 97 Latin America Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 98 Brazil Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 99 Argentina Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 100 MEA Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 101 South Africa Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 102 Saudi Arabia Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 103 UAE Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 104 Kuwait Allergy and Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 105 Strategy framework